Npt2a with NHERF-1, ezrin, and actin, and of PiT-1 with actin, may be responsible for membrane sorting and regulation of these Na/P i cotransporters in the osteoclast. phosphate transport; osteoclasts; Npt2a; NHERF-1; PiT-1 PHOSPHATE (P i ) is the major anionic component of the mineralized bone matrix (2) . Previously, we had hypothesized that during the process of bone resorption, part of the P i released from bone may be utilized by the osteoclast to maintain cellular ATP content during the cyclical processes of migration, attachment, and resorption (10) . In addition, we provided evidence for the expression of the type II family of Na/P i cotransporters in the osteoclast, identical or closely related to the type IIa cotransporter (Npt2a) in the renal proximal tubule (11) . The Npt2a protein mediates the rate-limiting step in renal P i reabsorption (27) . The importance of Npt2a in the regulation of extracellular P i was suggested by recent studies in which the Npt2a gene was inactivated in mice by targeted mutagenesis (3) . Previously, we examined the impact of Npt2a gene ablation on the skeletal phenotype in mice. At weaning, Npt2aϪ/Ϫ mice showed several skeletal abnormalities, including retarded secondary ossification, increased trabecular thickness, retention of growth plate proteoglycan in trabecular bone, and a reduction in osteoclast number. However, with increasing age, there was a correction of the skeletal phenotype (11) .
We demonstrated that the Npt2a-immunoreactive protein is localized exclusively on the basolateral membrane (BLM) and in areas contiguous to the sealing zone of the polarized osteoclast (10) . Disruption of the actin cytoskeleton in polarized osteoclasts with cytochalasin D inhibited P i uptake by ϳ80% (10) . Because Na/P i cotransport in the osteoclast is regulated by the actin cytoskeleton, we hypothesized that the Npt2a-immunoreactive protein in the osteoclast associates indirectly with the actin cytoskeleton and that this interaction may be a determinant of the plasma membrane localization and activity of Npt2a in the osteoclast.
The first aim of the present study was to identify a linker protein that would provide a bridge between the actin cytoskeleton and the Npt2a protein. In the kidney, Gisler et al. (9) identified a protein-binding V/ATXL domain in the COOH terminus of the Npt2a protein, representing a potential PDZ (PSD-95/Dlg/ZO-1)-interacting motif. PDZ domains are conserved protein modules that mediate protein-protein interactions associated with the plasma membrane (7) . One such PDZ protein, Na/H exchanger regulatory factor (NHERF-1), has been found to participate in regulation of phosphorylation, targeting, endocytic retrieval, and trafficking of several membrane transporters, including Npt2a in the kidney (9, 26) . In the present study, we undertook to determine whether the Npt2a protein also associates with NHERF-1 in the osteoclast, because this association may play a role in the cellular localization of Npt2a.
Previous studies have shown that Npt2a knockout (Npt2aϪ/Ϫ) mice exhibit an age-dependent increase in type III Na/P i cotransporter mRNA expression in the kidney as part of an effort to compensate for the loss of the Npt2a gene (12) . We hypothesized that the expression and regulation of the type III family of Na/P i cotransporters in the osteoclast could account for reversal of the skeletal phenotype in the Npt2aϪ/Ϫ mice (11) . Thus, in the present study, we sought to examine the expression and cellular localization of the type III family of Na/P i cotransporters in murine osteoclasts. The type III Na/P i cotransporters, originally identified as retroviral receptors for the gibbon ape leukemia virus (galv), are ubiquitously expressed and thought to function as housekeeping Na/P i cotransporters (14, 15) . One such galv receptor, PiT-1 (also known as Glvr-1), is expressed at high levels in bone marrow, osteoblasts, and chondrocytes (21, 23) .
Our study suggests that association of Npt2a with a PDZ protein such as NHERF-1, and of PiT-1 with actin, may play a role in membrane sorting and regulation of these Na/P i cotransporters in the osteoclast.
MATERIALS AND METHODS
Reagents. The enhanced green fluorescent protein (EGFP)-Npt2a constructs encoding for the wild type (WT) and COOHterminal TRL deletions (Npt2a-⌬TRL) were prepared as previously described (13) . Briefly, the mouse type IIa (mIIa) Na/P i cotransporters were fused to the COOH terminus of the EGFP by inserting the Npt2a (ϪWT and Ϫ⌬TRL) cDNAs into the pEGFP-C1 vector. Dr. Vijaya Ramesh (Molecular Neurogenetics Unit, Massachusetts General Hospital, Charlestown, MA) provided the glutathione S-transferase (GST)-NHERF-1 fusion protein. A rabbit osteoclast cDNA library was the gift of Dr. M. Kumegawa (Meikai University, Sakado, Japan) (28) . The murine macrophage (mMa) cDNA library was obtained from Stratagene (La Jolla, CA). Recombinant osteoprotegerin ligand (OPGL) was prepared as previously described (5) . Most reagents were of analytical grade and were purchased from Sigma (St. Louis, MO) unless otherwise indicated.
Mice. Mice (C57BL/6NHsd, 6-7-wk-old) were purchased from Harlan (Indianapolis, IN). Npt2a knockout mice were established by homologous recombination (3). Wild-type (Npt2aϩ/ϩ) and homozygous mutant (Npt2aϪ/Ϫ) mice, generated by crossing heterozygous (Npt2aϩ/Ϫ) male and female mice, were genotyped by PCR amplification of genomic DNA as previously described (3) .
Murine osteoclast culture. The tibiae and femurs of 7-wkold mice were used to isolate bone cells, as previously described (4, 11) . Bone marrow cells were suspended in ␣-minimal essential medium (␣MEM, GIBCO-BRL) supplemented with 10% fetal bovine serum (␣-10 MEM) and cultured at 37°C in a 5% CO 2 incubator. After 24 h, nonadhered cells were layered on Histopaque-1077 (Sigma) and centrifuged at 300 g for 15 min at room temperature. The cell layer between the Histopaque and the medium was removed and washed with ␣-10 MEM and then centrifuged at 2,000 rpm for 7 min. mCSF-1 (R & D Systems, Minneapolis, MN) was added to the cultures at a concentration of 10 ng/ml, and OPGL was added at 50-100 ng/ml. The multinucleated osteoclasts were seen to form and mature after day 4. Their viability was routinely assessed by trypan blue dye exclusion, and the percentage of tartrate-resistant acid phosphatase (TRAP)-positive cells was assessed to be ϳ99%, as previously described (11) .
Preparation of the GST-Npt2a fusion proteins. EGFPNpt2a constructs, encoding the WT and COOH-terminal TRL deletion (⌬TRL) cDNAs, were prepared as previously described (13) . These constructs served as templates for generation of the GST-Npt2a-WT and GST-Npt2a-⌬TRL fusion proteins. Npt2a-WT and Npt2a-⌬TRL fragments were PCR amplified by using the following primers: WT Npt2a: forward, 5Ј-CCGGAATTCATGTCCTGCAGAGCCGAA-3Ј, and reverse, 5Ј-CCGCTCGAGTAGAGGCGGGTAGCATT-3Ј; Npt2a-⌬TRL: forward, 5Ј-CCGGAATTCATGTCCTGCAGA-GCCGAA-3Ј, and reverse, 5Ј-CCGCTCGAGTAGCATTGTG-GTGAGCAG-3Ј. Amplification was carried out using a hot start method and Taq DNA polymerase (Life Technologies) with denaturation at 94°C for 1 min, annealing at 50°C for 1 min, and extension at 72°C for 1 min. At the end of 35 cycles, an extension cycle for 10 min at 72°C was performed. Both the Npt2a-WT (82 amino acids, 246 bp) and the Npt2a-⌬TRL (79 amino acids, 234 bp) fragments were directionally cloned into pGEX-5X-1 (Amersham Biosciences, Piscataway, NJ) at the EcoR1 and Xho1 sites. Positive clones were identified and confirmed by sequencing with pGEX-5Ј end primer. Subsequently, these clones were transformed in BL-21 cells. The GST-NHERF-1 (1-358 amino acids) fusion protein was provided in a pGex/BL21 construct by Dr. Vijaya Ramesh and was purified using a similar protocol.
Purification of GST-Npt2a fusion proteins. Overnight cultures of both the recombinant GST-Npt2a in BL-21 cells were transferred into larger volumes of LB/Amp, grown for 2 h until the OD600 was determined to be 1.0, and subsequently induced with 1.0 mM isopropyl-␤-D-thiogalactopyranoside (IPTG) for an additional 2 h at 37°C. Thereafter, the cultures were spun down at 2,500 rpm for 20 min. The pellets were resuspended in 3.6 ml of binding buffer that comprised 50 mM Tris-Cl, pH 8.0, 120 mM NaCl, 0.5% NP-40, 1 mM dithiothreitol (DTT), 1 mM phenylmethylsulfonyl fluoride (PMSF), and a protease inhibitor cocktail (Roche Diagnostics, Mannheim, Germany). Then, 0.4 ml of lysozyme (10 g/ml) was added, and the mixture was allowed to stand at room temperature for 20 min. The bacteria were lysed by repeated freeze-thaw cycles. The lysates were centrifuged at 14,000 rpm for 20 min. The supernatants were collected (ϳ4 ml) and incubated with 200 l of washed GST-Sepharose; these were rocked at room temperature for 1 h. The Sepharose beads were washed five times for 10 min each using 10 volumes of binding buffer. An aliquot of ϳ10 l of GST-bound proteins was taken and separated on 8% SDS-PAGE. After the extraction was confirmed, a 50% suspension of this extract was prepared with binding buffer and stored at 4°C.
Preparation of kidney homogenate and osteoclast cell lysates. Kidneys were homogenized in lysis buffer (10 mM Tris-Cl, pH 7.6, 150 mM NaCl, 1% NP-40, 10% glycerol plus protease inhibitor cocktail) for 1 h at 4°C. Osteoclast cell lysates were prepared in modified RIPA buffer (10 mM TrisCl, pH 7.4, 150 mM NaCl, 0.5% Triton X-100, 1% deoxycholic acid, 0.1% SDS, and 1% NP-40). The cells were spun down at 14,000 rpm at 4°C for 10 min. The supernatants were collected and bound to fusion proteins as detailed below.
GST-sepharose and nickel-agarose affinity-precipitation assays. To perform affinity-precipitation of NHERF-1, GSTbeads (Qiagen, Valencia, CA) bound to fusion proteins (Npt2a-WT or Npt2a-⌬TRL) or GST (control) were incubated with either (ϳ500 g) murine osteoclast or rat kidney (ϳ100 g) lysates at 4°C for 2-4 h. The beads were pelleted at 500 g for 2 min, washed four times with binding buffer, resuspended in 1-2 volumes of sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE) sample buffer, and boiled before fractionation on SDS-PAGE. The proteins were then transferred to polyvinylidene difluoride membranes (PVDF; Bio-Rad Laboratories, Hercules, CA) for Western analyses with a polyclonal antibody to NHERF-1 at a dilution of 1:1,000. A similar protocol was followed for incubation of murine osteoclast lysates with the GST-NHERF-1 fusion protein for affinity-precipitation of Npt2a. For the nickel (Ni)-agarose affinity-precipitation assays, the following conditions were used: Ni-agarose (Qiagen, Valencia, CA) beads (15 l) were incubated with 500 l of the 6XHis-tagged NHERF-1 fusion protein (0.2 mg/ml) for 1 h and subsequently incubated with ϳ500 g of murine osteoclast lysates overnight at 4°C. The beads were washed with washing buffer (50 mM NaH 2PO4, 300 mM NaCl, 20 mM imidazole, pH 8.0) three times for 10 min each. The beads were collected after centrifugation at 500 g for 2 min. Elution buffer (20 l, 50 mM NaH2PO4, 300 mM NaCl, 250 mM imidazole, pH 8.0) was added and incubated at 4°C for 1 h. The negative control for the Ni-agarose affinity-precipitation was performed by incubating osteoclast lysates with Niagarose beads alone in the absence of the 6XHis-tagged NHERF fusion protein. SDS-sample buffer was added to the beads and boiled, and the affinity precipitates were separated on SDS-PAGE. After transfer to PVDF membranes, the blots were probed with a polyclonal antibody to Npt2a at a 1:5,000 dilution, as previously described (10, 11) .
Western analysis of osteoclast and kidney lysates. Murine osteoclasts were used after day 5 in culture for preparation of lysates. After two quick rinses with ice-cold phosphate-buffered saline (PBS), the cells were lysed in a buffer containing 10 mM Tris ⅐ HCl, pH 7.05, 50 mM NaCl, 0.5% Triton X-100, 30 mM sodium pyrophosphate, 5 mM NaF, 0.1 mM Na3VnO4, 5 mM ZnCl2, and 2 mM PMSF. Lysates were pelleted by centrifugation at 15,000 rpm for 15 min at 4°C. The supernatant was transferred into a fresh microfuge tube and held on ice. Protein concentrations were measured using the BioRad protein assay reagent kit (Bio-Rad) so that equal amounts of protein were loaded per lane (5-50 g) and analyzed by SDS-PAGE on 8% gels. Western blot analyses were done as previously described (10, 11) . The gel was then electroblotted onto a PVDF membrane by wet-dry transfer (Enprotech, Integrated Separation Systems). Nonspecific protein binding was blocked with 5% nonfat dry milk powder dissolved in PBS containing 0.1% Tween 20. The blots were incubated overnight with a 1:5,000 dilution of the primary antibody to the Npt2a cotransporter. This was followed by detection with a horseradish peroxidase (HRP)-conjugated secondary goat anti-rabbit antibody (Sigma; 1:1,000 dilution). The secondary antibody (HRP-conjugated goat antirabbit antibody) was detected by the enhanced chemiluminescence (ECL) detection kit (Amersham Biosciences, Piscataway, NJ) following the manufacturer's instructions, and as previously described (10, 11) .
Transient transfection of murine osteoclasts with EGFPNpt2a-WT and Npt2a-⌬TRL. For transfection of osteoclasts, the osteoclast culture medium was replaced with serum-free (SF) MEM medium (SF-MEM). Approximately 0.8 g of each DNA (EGFP-Npt2a-WT/-Npt2a-⌬TRL) was used to transfect the cells with the transfection reagent Lipofectamine 2000 (Life Technologies) following the manufacturer's instructions. The DNA and Lipofectamine reagent complex was then added to the osteoclasts, and the plates were rocked gently before incubation for 4 h at 37°C, 5% CO 2. After the incubation, the SF-MEM medium was replaced with 10% serumcontaining MEM (␣-10 MEM) and incubated for 48 h at 37°C, 5% CO 2. These osteoclasts were then fixed and processed for immunostaining, as detailed below.
RT-PCR in the osteoclast and screening of cDNA library for PiT-1. Primers for amplification of murine PiT-1 were as follows: forward, 5Ј-CACCCATATGGCTTCTGCTT-3Ј, and reverse, 5Ј-CAGGAATTCATAGCCCAGGA-3Ј. The primers were chosen from the murine (kidney) PiT-1 sequence (GenBank accession no. M73696). The PCR reactions were performed using cDNA templates from RT reactions performed with equal quantities of total RNA isolated from murine osteoclasts and rat kidneys. The conditions for PCR-amplification of PiT-1 were as follows: an initial denaturation at 94°C for 4 min, followed by 35 cycles of 94°C for 1 min, annealing at 50°C for 1 min, and extension at 72°C for 1 min. A final extension was done for 10 min at 72°C. Two cDNA libraries (100 ng of template) were screened for PiT-1, one from rabbit osteoclasts (28) , and the other from murine macrophages (Stratagene), using the same primer pairs and PCR conditions mentioned above. The expected size of the PiT-1 amplicons was 600 bp, which was subsequently confirmed by sequencing.
In situ hybridization of PiT-1 in the murine osteoclast. In situ hybridization for PiT-1 mRNA in osteoclasts was performed, as previously described (27) . Murine osteoclasts were seeded on coverslips. The cells were washed in diethyl pyrocarbonate (DEPC)-PBS and fixed in 4% paraformaldehyde at room temperature for 20 min. The osteoclasts were permeabilized with 0.3% Triton X-100 for 15 min at room temperature. After the cells were rinsed in PBS, they were treated with proteinase K (5 g/ml) for 30 min at 37°C. To inactivate proteinase K, the osteoclasts were rinsed for 5 min at room temperature in 0.1 M glycine and PBS. The endogenous peroxidase was inhibited with 2% H2O2 in PBS for 30 min at room temperature. The osteoclasts were post fixed in 4% paraformaldehyde for 20 min at room temperature and acetylated for 5 min at room temperature with 0.25% acetic anhydride in 0.1 M triethanolamine (pH 8.0). Subsequently, the cells were rinsed with DEPC water and prehybridized at 48°C for 2 h in a humidified chamber. At the end of prehybridization, the osteoclasts were incubated successively with 50, 70, 95, and 100% ethanol; the dehydrated cells were denatured with 50% formamide solution in 2ϫ SSC for 10 min at 60°C and air-dried briefly. The cells were incubated overnight at 48°C with hybridization solution (50% form-amide, 5ϫ Denhardt's, 0.5 M NaCl, 50 mM dibasic sodium phosphate, 5 mM EDTA, 10 mM DTT, 0.5% SDS, 1% milk powder, and 0.1 mg/ml salmon sperm DNA) solution, containing heat denatured digoxigenin sense and antisense PiT-1 probes (2.5 ng/l) under humidified conditions. A separate set of osteoclasts was incubated with hybridization solution without any probes to serve as negative control. The cells were then washed in 2ϫ SSC for 5 min and with STE (500 mM NaCl, 1 mM EDTA and 20 mM Tris-Cl, pH 7.5) for 1 min at room temperature. The osteoclasts were washed with 50% formamide in 2ϫ SSC for 30 min at room temperature. The cells were then placed in buffer 1 (100 mM maleic acid, 100 mM NaCl, and 0.3% Triton X-100, pH 7.5) for 5 min and blocked with buffer 1 containing 10% normal horse serum for 1 h at room temperature. For antibody visualization of digoxigenin, the osteoclasts were further incubated with anti-digoxigenin alkaline phosphatase-conjugated antibody (diluted 1:500) in blocking solution at 4°C overnight in a humidified chamber. These cells were rinsed successively in buffer 1 and buffer 3 (100 mM Tris, 100 mM NaCl, and 50 mM MgCl 2, pH 9.5). To each of the wells containing osteoclasts on the coverslips, 1 ml of NBT-BCIP (Roche Diagnostics) staining solution (that was prepared just before use) was added and incubated overnight at room temperature in the dark. After 24 h, cells were washed in DEPC-PBS, mounted, and visualized using a Nikon E800 microscope equipped with a SPOT camera (Diagnostic Instruments, Alexandria, VA).
Construction of the retroviral vector encoding for PiT-1. PiT-1 was tagged at the carboxy terminus by subcloning PiT-1 cDNA into the pSC2-HA plasmid containing a double HA epitope tag (YPYDVPDYA), derived from influenza hemagglutinin (6) . Using PCR mutagenesis, a segment of PiT-1 cDNA was amplified using primers 5Ј-CCATGGCAATATGT-GGCATGCC-3Ј (sense) and 5Ј-CAAACAGAGCTCCATTCT-GAGGATGACC-3Ј (antisense), resulting in the removal of the stop codon and the introduction of a SacI site (underlined). The modified PiT-1 cDNA was subcloned into the pSC2-HA plasmid between HindIII and SacI in the same reading frame as the HA tag. The HA-tagged PiT-1 cDNA was then digested with HindIII and StuI and subcloned into the retroviral vector pLNSX between HindIII and ClaI, which was filled in using T4 DNA polymerase to create the pLNSPiT1-HA plasmid. Vector particles were produced, as previously described (8) .
Immunostaining of osteoclast cultures. Murine osteoclasts were rinsed twice in ice-cold PBS, fixed with 3% paraformaldehyde, and permeabilized with PBS containing 0.2% Triton X-100. The cells were blocked with PBS containing 2% bovine serum albumin (BSA) overnight. The cells were incubated for 2 h in a 1:500 dilution of the primary antibody at room temperature in the blocking solution described above. In experiments to determine the cellular distribution of NHERF-1 and Npt2a, NHERF-1 was detected with a chicken (IgY) polyclonal antibody, whereas Npt2a was detected with a rabbit (IgG) polyclonal COOH-terminal antibody. After two 15-min rinses with PBS containing 0.1% Tween 20, the cells were further incubated with rhodamine phalloidin (Sigma) to stain the actin cytoskeleton, as previously described (10, 11) . The transfected pool of Npt2a was detected by fluorescence of EGFP. Epifluorescence was detected with either a Nikon Eclipse 800 microscope equipped with a SPOT camera (Diagnostic Instruments, Alexandria, VA) or a Bio-Rad Radiance 2100 confocal microscope. Confocal microscopy (Bio-Rad Radiance 2100) for immunostaining of Npt2a and NHERF-1 was performed with an Alexa-568-conjugated goat anti-rabbit antibody and Alexa-488-conjugated goat anti-chicken antibody (Molecular Probes), respectively. All images shown were taken with a Plan Apo ϫ60/1.4 na oil-immersion objective lens. The lateral (xy) resolution at this magnification was 0.12-0.17 m.
RESULTS

Validation of Npt2a protein expression in normal mouse osteoclasts.
We have previously demonstrated that an Npt2a-like protein was present in the osteoclast, which was either closely related or identical to that in the kidney (10, 11 ). In the current study, we have definitively established the identity of the Npt2a protein in the osteoclast by Western analysis of osteoclast lysates isolated from Npt2aϩ/ϩ and Npt2aϪ/Ϫ mice. Using a COOH-terminal antibody to Npt2a, we detected an 88-kDa protein in osteoclast lysates from Npt2aϩ/ϩ but not in Npt2aϪ/Ϫ mice (Fig. 1A , lanes 1 and 2; ϳ80 g protein/lane). As controls for the Western blots, murine kidney homogenates (ϳ25 g protein/lane) were isolated from Npt2aϩ/ϩ and Npt2aϪ/Ϫ mice (Fig. 1B, lanes 1 and 2) . As expected, there was no detectable signal in Npt2aϪ/Ϫ mice. The individual Western blots for Npt2a in osteoclast and kidney lysates were reprobed for actin to demonstrate protein loading for each lane. Cellular distribution of Npt2a, actin, and NHERF-1 in the osteoclast. We previously showed that Npt2a is localized almost exclusively on the basolateral membrane, near the sealing zone of the polarized osteoclast on bone (10, 11) . In the present study, we examined the nature of the association of Npt2a with the actin cytoskeleton. Murine osteoclasts, cultured on glass, were immunostained for Npt2a (FITC, green), while actin was stained with rhodamine phalloidin (red). The localization of Npt2a is contiguous to the actin cytoskeleton, as shown in Fig. 2A . Significant colocalization of Npt2a with the actin ring near the periphery of the osteoclast was evident, as indicated in yellow. NHERF-1 is associated with various membrane transporters (31) and is generally classified as a membranecytoskeletal adaptor protein. We showed that NHERF-1 can be readily detected in the murine osteoclast by Western blotting (Fig. 2B, lane 2) using a previously characterized polyclonal antibody to NHERF-1 (30) . We used rat kidney homogenates (Fig.  2B, lane 1) as a positive control for the Western blot. The NHERF-1 antibody recognizes an ϳ50-kDa protein in several species, including rat, human, and mouse (25, 30) .
We then examined the cellular distribution of NHERF-1 in the murine osteoclast. In the representative confocal image of the osteoclast that was immunostained for NHERF-1, at least 13 nuclei can be seen, distributed toward the periphery. NHERF-1 was found to be localized predominantly at or near the plasma membrane, with some perinuclear staining, as shown (Fig. 2C) . We next examined the possibility that the cellular distribution of Npt2a is contiguous or colocalized with that of NHERF-1 in the polarized osteoclast. For this purpose, we performed immunofluorescence in murine osteoclasts plated on 1-m CaPO 4 -coated Osteologic discs, a substrate on which osteoclasts are polarized, as previously described (10) . Both NHERF-1 (Fig. 2Da) and Npt2a (Fig. 2Db) proteins colocalized near the periphery of the osteoclast (Fig. 2Dc) .
Confocal microscopy was used to examine the cellular distribution of Npt2a and NHERF-1 in the osteoclast in more detail (Fig. 2E, a-c) . As shown, NHERF-1 is localized primarily at the osteoclast plasma membrane (Fig. 2Ea) . A similar cellular distribution pattern was obtained for Npt2a (Fig. 2Eb) , and, given the limits of the confocal optics (i.e., the lateral resolution at this magnification was 0.12-0.17 m), the two pro- teins colocalized in a punctate manner at the osteoclast plasma membrane, with additional diffuse central/perinuclear staining (Fig. 2Ec) .
Interaction of NHERF-1 with Npt2a: affinity-precipitation assays. Having established that Npt2a and NHERF-1 are present in the osteoclast, we examined whether Npt2a associates with the adaptor protein.
NHERF-1 was produced as a GST fusion protein and incubated with murine osteoclast lysates, and the affinity precipitates with GST-NHERF-1 were Western blotted for Npt2a. The signal for Npt2a in murine osteoclast lysates is shown (Fig. 3A, lane 1) ; there was no signal obtained for Npt2a when the GST protein itself was incubated with murine osteoclast lysates (Fig. 3A, lane 2) . The Npt2a protein could be detected when rat kidney lysates were incubated with GST-NHERF-1 (Fig. 3A, lane 3) . A signal for Npt2a was also detected when murine osteoclast lysates were incubated with the GST-NHERF-1 fusion protein (Fig. 3A,  lane 4) . These findings were further corroborated using Fig. 3 . Interaction of Npt2a with NHERF-1. A: glutathione S-transferase (GST)-NHERF-1 was used for affinityprecipitation of Npt2a in rat kidney homogenates (rKid, ϳ100 g) and murine osteoclast lysates (mOC, ϳ500 g). Lane 1: Western blot for Npt2a obtained from murine osteoclast lysates (mOC, ϳ50 g); lane 2: as a negative control, GST protein itself was incubated with murine osteoclast lysates (mOC ϩ GST). Signal for Npt2a in the GST-NHERF-1 affinity-precipitation from rat kidney homogenates (rKid ϩ GST-NHERF-1, lane 3) and signal for Npt2a when murine osteoclast lysates were incubated with the GST-NHERF-1 fusion protein (mOC ϩ GST-NHERF-1, lane 4) are shown. B: murine osteoclast lysates were used for affinity-precipitation of Npt2a with nickel (Ni)-agarose-NHERF-1. Npt2a was detected by Western blotting. Lane 1: negative control in the absence of the 6XHis-tagged NHERF-1 fusion protein (Ni-agarose). Lane 2: signal for murine osteoclast lysates incubated with NHERF-1-Ni-agarose beads (NHERF-1-Ni-agarose). Lane 3: signal for Npt2a in total murine osteoclast lysates as positive control (mOC). C: GST-Npt2a fusion proteins were used for affinity-precipitation of NHERF-1 from rat kidney homogenates. NHERF-1 was detected by Western blotting. The GST-Npt2a fusion proteins encoded either the wild-type (WT) COOH-terminal fragment of Npt2a (Npt2a-WT, COOH-terminal 82 amino acids) or the truncated COOH-terminal fragment of Npt2a where the TRL motif was deleted (Npt2a-⌬TRL, COOH-terminal 79 amino acids). Lane 1: Western blot for NHERF-1 as positive control (rKid); lane 2: negative control for affinityprecipitation of NHERF-1 (rKid ϩ GST); lane 3: affinity-precipitation of NHERF-1 (rKid ϩ GST-Npt2a-⌬TRL); and lane 4: affinity-precipitation of NHERF-1 (rKid ϩ GST-Npt2a-WT). D: GST-Npt2a-WT or GST-Npt2a-⌬TRL fusion proteins were used for affinity-precipitation of NHERF-1 from murine osteoclast lysates. NHERF-1 was detected by Western blotting. Lane 1: Western blot for NHERF-1 as positive control (mOC); lane 2: negative control for affinity-precipitation of NHERF-1 (mOC ϩ GST); lane 3: affinity-precipitation of NHERF-1 (mOC ϩ GST-Npt2a-WT); and lane 4: affinity-precipitation of NHERF-1 (mOC ϩ GST-Npt2a-⌬TRL). E: affinity-precipitation of ezrin with GST-Npt2a fusion proteins in osteoclasts. The immunoblots from affinity-precipitation of NHERF-1 with GST-Npt2a-WT or -⌬TRL fusion proteins (in D) were stripped and reprobed with a monoclonal antibody to ezrin. 6XHis-tagged NHERF-1 bound to Ni-agarose beads and incubated with murine osteoclast lysates (Fig. 3B) . In the absence of 6XHis-tagged NHERF-1, there was very little binding of Npt2a to Ni-agarose (Fig. 3B, lane  1) ; however, Npt2a was bound to the 6XHis-tagged NHERF-1 (Fig. 3B, lane 2) . The signal for Npt2a in the osteoclast lysates is also shown (Fig. 3B, lane 3) . Taken together, these experiments suggest an association of Npt2a with NHERF-1 in the osteoclast.
The association of Npt2a with NHERF-1 has been localized to the carboxy terminus of Npt2a, which has a TRL motif, as previously reported (9) . Yeast twohybrid assays had shown that the interaction of Npt2a with NHERF-1 is abrogated when the PDZ-binding motif was deleted. To examine whether this COOHterminal PDZ-binding motif was indeed critical in the association of Npt2a with NHERF-1, we performed in vitro GST affinity-precipitation assays using either the WT COOH-terminal fragment of Npt2a or the truncated COOH terminus fragment of Npt2a where the TRL motif was deleted. First, rat kidney homogenates (rKiD) were incubated with the GST-Npt2a-WT and GST-Npt2a-⌬TRL fusion proteins; the affinity precipitates were Western blotted with the NHERF-1 antibody. The signal for NHERF-1 can be detected in rat kidney homogenates (Fig. 3C, lane 1) ; there was no detectable signal for NHERF-1 when the GST protein alone was incubated with rat kidney homogenates (Fig.  3C, lane 2) . However, NHERF-1 could be detected with both the GST-Npt2a-⌬TRL (Fig. 3C, lane 3) and GSTNpt2a-WT (Fig. 3C, lane 4) , although the levels of NHERF-1 associated with the GST-Npt2a-⌬TRL fusion protein were far less compared with that precipitated with the GST-Npt2a-WT fusion protein. Therefore, these GST affinity-precipitation studies show that although the COOH-terminal TRL motif of Npt2a is important for binding NHERF-1 in the kidney, the interaction of Npt2a with NHERF-1 is not completely lost in the absence of the PDZ motif.
Next, we performed similar GST affinity-precipitation studies using murine osteoclasts. Murine osteoclast lysates were incubated with the GST-Npt2a-WT and GST-Npt2a-⌬TRL fusion proteins; these affinity precipitates were probed with the NHERF-1 antibody. Our results are summarized as follows in Fig. 3D, lanes  1-4. The signal for NHERF-1 can be detected in osteoclast lysates (Fig. 3D, lane 1) ; there was no discernible signal for NHERF-1 when the GST protein alone was incubated with murine osteoclast lysates (Fig. 3Cb,  lane 2) . NHERF-1 could be detected with both the GST-Npt2a-WT (Fig. 3D, lane 3) and GST-Npt2a-⌬TRL (Fig. 3D, lane 4) . However, the levels of NHERF-1 associated with the GST-Npt2a-⌬TRL fusion protein were only slightly reduced compared with that of the GST-Npt2a-WT fusion protein, in contrast to our findings in the kidney. This suggests that although the Npt2a protein in the osteoclast is identical or closely related to that in the kidney, its binding affinity to NHERF-1 may differ from that in the kidney.
The ezrin-radixin-moesin (ERM)-complex is known to mediate the interaction between NHERF-1 and actin (1). We hypothesized that ezrin would comprise a link between Npt2a-NHERF-1 and actin in the osteoclast. To examine this possibility, the immunoblots for the GST-Npt2a-NHERF-1 affinity-precipitations (Fig.  3D) were stripped and reprobed with a monoclonal antibody to ezrin (Fig. 3E, lanes 1-4) . The signal for ezrin can be seen at ϳ80 kDa in murine osteoclast lysates, as shown in Fig. 3E , lane 1. When murine osteoclast lysates were incubated with GST protein alone, ezrin did not coprecipitate (Fig. 3E, lane 2) . Ezrin was readily detectable when murine osteoclast lysates were incubated with GST-Npt2a-WT fusion protein (Fig. 3E, lane 3) . The levels of ezrin that were detectable in affinity precipitates with GST-Npt2a-⌬TRL fusion protein were noticeably lower compared with that obtained with the GST-Npt2a-WT fusion protein (Fig. 3E, lane 4) . The likely explanation for these findings is that NHERF-1 binds ezrin directly and that the association of Npt2a with ezrin is indirectly mediated by NHERF-1.
Cellular distribution of Npt2a-WT and Npt2a-⌬TRL in murine osteoclasts. NHERF-1 has been implicated in the membrane sorting of several transporters (26) . We next asked whether there were any differences in sorting of the Npt2a-WT and Npt2a-⌬TRL proteins in the osteoclast. Although osteoclasts are notorious for being resistant to conventional methods of transfection, transfection can be achieved in a small percentage of cells in culture (18) . First, we plated murine osteoclasts on glass coverslips, which were then transfected with either the Npt2a-WT or the Npt2a-⌬TRL constructs in an EGFP vector, as shown in Fig. 4A, lanes 1-3. As a control for the EGFP-derived fluorescence, murine osteoclasts were also transfected with the empty EGFP vector. The osteoclasts were subsequently processed for EGFP-derived immunofluorescence 48 h later. As shown in the EGFP-control cells, there was a low level of diffuse fluorescence due to the EGFP alone (Fig. 4A,  lane 1) . In osteoclasts that were transfected with EGFP-Npt2a-WT, the cellular distribution of EGFPNpt2a was seen as both perinuclear and peripheral near the plasma membrane, as indicated by the arrow (Fig. 4A, lane 2) . In contrast, the cellular distribution of EGFP-Npt2a-⌬TRL was apparent as mostly perinuclear and weak staining at the plasma membrane, as indicated by the arrow (Fig. 4A, lane 3) .
We next examined the cellular distribution of the EGFP-Npt2a-WT and EGFP-Npt2a-⌬TRL proteins in osteoclasts that were actively involved in resorption by confocal microscopy. When murine osteoclasts are plated on 1-m-thick CaPO 4 -coated quartz discs, the matrix is actively resorbed and the resorbed areas can be visualized as clear areas on the quartz disc, as shown in Fig. 4B . On this substrate, murine osteoclasts can form multiple actin rings within one cell, which are normally associated with resorption centers (10) . Murine osteoclasts plated on CaPO 4 -coated quartz discs were transfected with either EGFP-Npt2a-WT or EGFP-Npt2a-⌬TRL and after 48 h were fixed and stained for actin with rhodamine phalloidin. The signal for EGFP-Npt2a-WT was seen to colocalize with the actin ring, as indicated in yellow (Fig. 4C, lane 1) . Using identical confocal settings, the signal EGFPNpt2a-⌬TRL was also seen to colocalize with two actin rings, as shown within one representative osteoclast (Fig. 4C, lane 2) . Although the fluorescence was not quantified, it was apparent that the intensity of the EGFP-Npt2a-⌬TRL signal that colocalized with actin was somewhat less than that for the corresponding EGFP-Npt2a-WT signal. In summary, these immunofluorescence data suggest that in spite of the absence of the COOH-terminal NHERF-1-binding TRL motif, Npt2a can still associate with actin in osteoclasts actively involved in resorption.
Expression of PiT-1 in osteoclasts. Previous studies demonstrated that hypophosphatemia in Npt2a knockout mice (Npt2aϪ/Ϫ) resulted in an age-dependent increase in type III Na/P i cotransporter mRNA expression in the kidney as part of an effort to compensate for the loss of the Npt2a gene (12) . Given the evidence that expression of other Na/P i cotransporters can increase in the Npt2aϪ/Ϫmice, we asked whether the type III family of Na/P i cotransporters is expressed in the osteoclast. As previously mentioned, PiT-1 is one such galv receptor that is highly expressed in bone marrow, osteoblasts, and chondrocytes (19, 20, 22, 29) . In our preliminary studies, we demonstrated the expression of PiT-1 in murine osteoclasts by RT-PCR, using total RNA isolated from murine osteoclasts, as shown in Fig.  5A, lanes 1-4. A 600-bp amplicon was obtained for both the murine osteoclast PiT-1 (Fig. 5A, lane 2) and the rat kidney PiT-1 (Fig. 5A, lane 3) . In the absence of RT, no product was obtained from kidney RNA (Fig. 5A,  lane 4) . The sequence identity between the rat kidney and the murine osteoclast PiT-1 was 98%. Previously, we had successfully established the presence and identity of the Npt2a gene by PCR-based cloning of a rabbit osteoclast and a mouse macrophage cDNA library (10, 11) . In the current study, to further establish the presence of PiT-1 in osteoclasts, we detected PiT-1 by PCR-screening of the cDNA library generated from rabbit osteoclasts (rOC cDNA), as shown (Fig. 5B, lane  2) ; PiT-1 could also be detected in a murine macrophage cDNA library (Fig. 5B, lane 3) . There was no detectable signal for PiT-1 in the absence of cDNA template (Fig. 5B, lane 4) . Therefore, these data suggest that both the osteoclast and the macrophage express the PiT-1 transporter. To prove that the RT-PCR signal for PiT-1 was indeed originating from osteoclastic cells, we decided to perform in situ hybridization for PiT-1 in murine osteoclasts in culture. No signal was detected in osteoclasts hybridized with sense digoxigenin-labeled riboprobes for PiT-1 (Fig. 5A, lanes 1-3) . However, a signal was detected in osteoclasts hybridized with antisense digoxigenin-labeled riboprobes for PiT-1, as shown in the brown-yellow color (Fig. 5B,  lanes 1-3) . Osteoclasts that were not hybridized with either sense or antisense riboprobes for PiT-1 served as negative controls (Fig. 5C) . Therefore, our in situ results, combined with those obtained from RT-PCR and PCR-based amplification of PiT-1 from (osteoclast and macrophage) cDNA libraries, suggest that PiT-1 is expressed in the osteoclast and osteoclast-like cells.
Cellular distribution of PiT-1 in osteoclasts. Currently, there are no antibodies available for PiT-1. To circumvent this limitation, we infected murine osteoclasts with a retroviral vector carrying a replicationdeficient retrovirus that contains a HA-tagged PiT-1 cDNA, as shown in Fig. 6A . This provides a highefficiency gene transfer of a HA-tagged PiT-1 into osteoclasts. Murine osteoclasts plated on glass coverslips were assayed for immunofluorescence 48 h postinfection with the retrovirus. Actin was labeled with rhodamine phalloidin, whereas PiT-1 immunofluorescence was detected using an HA antibody. As can be seen, the punctate cellular distribution of PiT-1 is contiguous to that of actin, at or near the plasma membrane, as indicated in yellow. Similar results were obtained with two different dilutions of the retrovirus encoding for PiT-1 (1:1,000 and 1:500). Next, murine osteoclasts were plated on 1-m-thick CaPO 4 -coated Osteologic discs, as previously described (10) . Osteoclasts become polarized and avidly resorb the matrix (10) . Murine osteoclasts were infected with the retrovirus-encoded HA-tagged PiT-1 for 48 h. PiT-1 was seen to colocalize with the actin ring, as shown in the representative osteoclast (Fig. 6B) . Next, we used confocal microscopy to assess the polarity of the PiT-1 distribution, as shown in an xz (cross section) view of the osteoclast (Fig. 6C, lane 1) . The transporter was found to localize almost exclusively to the basolateral membrane and the sealing zone, similar to that previously reported for the Npt2a cotransporter. The planar optical section that was used to generate the cross-sectional view of the osteoclast is shown (Fig. 6C, lane 2) . The cellular distribution of PiT-1 is punctate on the basolateral surface of the polarized osteoclast.
DISCUSSION
We previously demonstrated that an Npt2a-like Na/P i cotransporter is expressed in the osteoclast and is exclusively localized to the basolateral membrane of the polarized osteoclast (10, 11) . In addition, we showed that phosphonoformic acid, a selective inhibitor of Na/P i cotransport, greatly diminished the resorptive capacity of osteoclasts and that disruption of the actin cytoskeleton in osteoclasts greatly diminished Na-dependent P i uptake (10) .
In the present study, we demonstrate that Npt2a protein in the osteoclast is identical to that in the kidney as previously suggested (10, 11) and is absent from Npt2a-null osteoclasts. We also demonstrate, using GST-fusion protein affinity-precipitation assays, that the Npt2a protein in the osteoclast interacts with the PDZ-domain protein NHERF-1. Previous studies using the yeast two-hybrid system indicated that the TRL motif of Npt2a is critical for binding to NHERF-1 as well as other PDZ-domain proteins in the kidney (9) . Some of these PDZ proteins are localized in the brush border or in the subapical compartment of proximal tubular cells. These proteins include NaP i -Cap1 and NaP i -Cap2, identical to diphor-1 and PDZK1 (16, 17) . It has been suggested that because PDZ proteins also interact with the actin cytoskeleton, they contribute to the stabilization of proteins at or near the plasma membrane (26) .
The yeast two-hybrid studies also suggested that removal of the COOH-terminal amino acid residues, TRL, blunted the interaction of the Npt2a cotransporter with NaP i -Cap1, NaP i -Cap2, NHERF-1, and NHERF-2 (9). This conclusion was based on the lack of ␤-galactosidase activation by the TRL-truncated COOH-terminal tail of Npt2a; however, no GST affinity-precipitation assays were performed with either the full-length or the truncated Npt2a construct. In our studies, we subcloned fragments of the Npt2a cDNA that spanned 82 amino acids from the COOH terminus (the GST-Npt2a-WT fusion protein), or 79 amino acids that lacked the terminal TRL domain at the COOH Fig. 6 . Cellular distribution of PiT-1 in the osteoclast. Murine osteoclasts were plated either on glass coverslips (where they are unpolarized) or on resorbable CaPO4-coated matrices (where they are polarized). These osteoclasts were infected with a retroviral vector carrying a replication-deficient retrovirus that contained a HA-tagged PiT-1 cDNA. Actin was labeled with rhodamine phalloidin, and PiT-1 immunofluorescence was detected using an HA antibody. A: PiT-1 in unpolarized osteoclasts. Scale bar represents 10 m. B: PiT-1 in polarized osteoclasts. Scale bar represents 20 m. C: basolateral localization of PiT-1. 1: cross-sectional (xz) view of the polarized osteoclast and distribution of PiT-1, using confocal microscopy. The top arrow points to the basolateral membrane, whereas the bottom arrow points to the matrix. A planar optical section of the basolateral membrane of the osteoclast is also shown (2) . Scale bar represents 20 m.
terminus (the GST-Npt2a-⌬TRL fusion protein). Our in vitro GST affinity-precipitation studies indicate that the TRL motif in Npt2a is not the sole determinant for binding to NHERF-1, either in the kidney or in the osteoclast. Using rat kidney homogenates, we found that when the PDZ-binding motif was deleted, NHERF-1 was still recovered, although the recovery was far less than that with the WT Npt2a protein, consistent with our recent demonstration that the COOH-terminal TRL motif of Npt2a is not the sole determinant of apical membrane expression in polarized opossum kidney (OK) cells (13) . An upstream proline-arginine (P 578 R 579 ) sequence appeared to play an additional role in membrane expression of the Npt2a protein (13). Our affinity-precipitation studies using the GST-Npt2a-WT and GST-Npt2a-⌬TRL fusion proteins contain the upstream PR sequence, which may explain the finding that Npt2a lacking the COOHterminal TRL motif can still bind NHERF-1. It is of interest, however, that nearly identical findings have been found using similar Npt2a fusion proteins in affinity-precipitation assays in a renal epithelial cell line, suggesting that NHERF-1 and Npt2a may bind at more than one site (Lederer ED and Weinman EJ, unpublished observations). Moreover, a similar paradigm may also characterize the interaction between NHERF-1 and NHE3 (Weinman EJ, unpublished observations). The nature of the putative alternate site or sites of interaction between NHERF-1 and Npt2a remains to be determined.
We have shown that Npt2a associates indirectly with ezrin in the osteoclast, a finding that may explain the indirect association with the actin cytoskeleton. In the kidney, NHERF-1 is predominantly found in brushborder membranes, with a minor fraction in the basolateral membrane and in the cytosol (30) . These separate pools of NHERF-1 have been hypothesized to shuttle between the different membrane domains to regulate ion transport. NHERF-1 associates with an NH 2 -terminal ezrin/radixin/moesin domain (ERMAD), conserved in proteins that belong to the ERM family of actin-binding proteins, serving as a membrane-cytoskeleton bridge; several studies have suggested that various transporters are linked to the actin cytoskeleton through the NHERF-1-ERM complex (26) . This association between NHERF and the ERM complex may determine the membrane sorting of Npt2a in the osteoclast. We found some discernible differences in the sorting of the Npt2a-WT and the Npt2a-⌬TRL proteins in the osteoclast, as seen from our immunofluorescence studies. In actively resorbing osteoclasts, multiple actin rings were seen to form, which delineated areas of resorptive activity. There was a redistribution of the Npt2a (WT and ⌬TRL) protein, from the plasma membrane to these actin rings. However, in nonresorbing osteoclasts (plated on glass), our immunofluorescence data indicate that the plasma membrane localization of the Npt2a-WT protein is more intense than that of Npt2a-⌬TRL. This observation is consistent with findings in opossum kidney (OK) cells, where the TRL-truncated Npt2a cotransporter was still partially expressed at the apical membrane, although part of it was detected inside the cell (13) . Indeed, an upstream sequence (i.e., P 578 R 579 ) is also involved in apical expression of the cotransporters (13) . Mutation of this PR motif, or removal of all downstream residues, resulted in almost a total loss of apical membrane expression of Npt2a in OK cells. It was suggested that there was an "unmasking" of this internal PR motif after removal of several amino acid residues upstream of the COOH-terminal TRL motif. The question remains whether the internal PR sequence functions as a sorting signal or as an anchoring determinant for Npt2a in the osteoclast or the kidney. Future studies, using either adenoviral or retroviral vectors for high-efficiency gene transfer, will permit a more in-depth investigation of the activity and sorting behavior of Npt2a-WT and the Npt2a-⌬TRL proteins. Furthermore, the application of pulse chase and surface biotinylation strategies will facilitate the study of Npt2a half-life and membrane sorting in osteoclasts and kidney derived from NHERF-1 null mice (25) .
We have previously reported that the hypophosphatemia in young Npt2aϪ/Ϫ mice is associated with skeletal abnormalities and a mild osteoclast defect (11) . The absence of a more flagrant osteopetrotic phenotype in Npt2aϪ/Ϫ mice suggested that other P i transport mechanism(s) in the osteoclast compensate(s) for the deficiency of Npt2a. We have hypothesized that the type III family of Na/P i cotransporters may adapt to the lack of the Npt2a protein in osteoclasts (11) . In the present study we demonstrate that PiT-1, a member of the type III family of Na/P i cotransporters, is expressed in the murine osteoclast. This was accomplished by RT-PCR of RNA isolated from osteoclasts in culture and PCR-based screening of an osteoclast cDNA library. Moreover, our preliminary data show that PiT-1 in the osteoclast is probably identical to that found in the kidney.
We have also demonstrated that PiT-1 is localized to the basolateral membrane of the polarized osteoclast and that its distribution in the osteoclast is similar to what we previously reported for Npt2a (10) . Moreover, the colocalization of PiT-1 with actin in the polarized osteoclast is consistent with the plasma membrane localization of PiT-1. It is of interest that the receptor for amphotropic murine leukemia viruses, PiT-2, has been reported to associate with actin in CHO cells (24) . The colocalization of PiT-2 with actin in these cells can be modified by variations in concentration of extracellular P i (24) . On the basis of these findings, it was postulated that changes in the actin cytoskeleton (such as formation of stress fibers) may be responsible for conformational changes in PiT-2 that in turn determine its activity as a P i transporter. Although PiT-1 does not contain any recognizable PDZ-binding motifs that may mediate an indirect association with actin, the activity of PiT-1 in the osteoclast in response to ambient P i levels may be linked to changes in the osteoclast actin network that occur during attachment to bone matrix and subsequent resorption. Future studies are necessary to assess the relative contribu-tion of PiT-1 to osteoclast function in both WT and Npt2aϪ/Ϫ mice.
